142 related articles for article (PubMed ID: 18640030)
1. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands.
Sukel MP; van de Poll-Franse LV; Nieuwenhuijzen GA; Vreugdenhil G; Herings RM; Coebergh JW; Voogd AC
Eur J Cancer; 2008 Sep; 44(13):1846-54. PubMed ID: 18640030
[TBL] [Abstract][Full Text] [Related]
2. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
3. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or].
Coudert B; Chaplain G; Milan C; Janoray P
Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology].
Bontenbal M; Nortier JW; Beex LV; Bakker P; Hupperets PS; Nooij MA; van Veelen H; Vreugdenhil G; Richel DJ; Blijham GH
Ned Tijdschr Geneeskd; 2000 May; 144(21):984-9. PubMed ID: 10858788
[TBL] [Abstract][Full Text] [Related]
6. Variation in management of early breast cancer in the Netherlands, 2003-2006.
van Steenbergen LN; van de Poll-Franse LV; Wouters MW; Jansen-Landheer ML; Coebergh JW; Struikmans H; Tjan-Heijnen VC; van de Velde CJ
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S36-43. PubMed ID: 20620013
[TBL] [Abstract][Full Text] [Related]
7. Changing practice in systemic breast cancer adjuvant treatment in a well-defined French population.
Chaplain G; Coudert B; Milan C; Altwegg T; Esteve J
Bull Cancer; 1999 Oct; 86(10):855-60. PubMed ID: 10572236
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients.
Bastiaannet E; Liefers GJ; de Craen AJ; Kuppen PJ; van de Water W; Portielje JE; van der Geest LG; Janssen-Heijnen ML; Dekkers OM; van de Velde CJ; Westendorp RG
Breast Cancer Res Treat; 2010 Dec; 124(3):801-7. PubMed ID: 20428937
[TBL] [Abstract][Full Text] [Related]
9. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005.
Kemetli L; Rutqvist LE; Jonsson H; Nyström L; Lenner P; Törnberg S
Acta Oncol; 2009; 48(1):59-66. PubMed ID: 18752084
[TBL] [Abstract][Full Text] [Related]
13. The management of early breast carcinoma before and after the introduction of clinical practice guidelines.
White V; Pruden M; Giles G; Collins J; Jamrozik K; Inglis G; Boyages J; Hill D
Cancer; 2004 Aug; 101(3):476-85. PubMed ID: 15274060
[TBL] [Abstract][Full Text] [Related]
14. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands.
Louwman WJ; Voogd AC; van Dijck JA; Nieuwenhuijzen GA; Ribot J; Pruijt JF; Coebergh JW
Cancer Causes Control; 2008 Feb; 19(1):97-106. PubMed ID: 18038250
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.
Barthélémy P; Heitz D; Mathelin C; Polesi H; Asmane I; Litique V; Rob L; Bergerat JP; Kurtz JE
Crit Rev Oncol Hematol; 2011 Aug; 79(2):196-204. PubMed ID: 20655243
[TBL] [Abstract][Full Text] [Related]
16. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
Görner M; Just M; Gerull S
Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
[TBL] [Abstract][Full Text] [Related]
17. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
18. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
19. [Trends in breast cancer treatment in the elderly at a breast cancer outpatient clinic: guidelines followed better].
Hamaker ME; Schreurs WH; van Slooten HJ; Uppelschoten JM; Smorenburg CH
Ned Tijdschr Geneeskd; 2009; 153():A562. PubMed ID: 19930741
[TBL] [Abstract][Full Text] [Related]
20. [Breast cancer in patients, 70 years or older].
Hillen HF; Hupperets PS
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1099-104. PubMed ID: 10876704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
